GlassScriptPhysician profile
Jessica Liu
NPI 1942736541
$3,780.92
in general payments reported to CMS, 2019-2025
16 companies · $469 in 2025
The $469 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $156 · 2021: $840 · 2022: $723 · 2023: $478 · 2024: $773 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,719.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,287.28 | 2019-2025 | Hydrus Microstent, Voyager Dslt, Clareon |
| Abbvie INC. | $721.17 | 2022-2025 | |
| Sight Sciences, INC. | $671.06 | 2021-2024 | Omni Surgical System |
| Bausch & Lomb Americas INC. | $217.49 | 2023-2025 | Xiidra, Miebo, Vyzulta |
| Allergan, INC. | $188.02 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $142.06 | 2019 | |
| New World Medical,INC. | $137.16 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $121.86 | 2024 | Tecnis Iol |
| Rxsight INC | $86.15 | 2023-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Amgen INC. | $60.48 | 2024 | Tepezza |
| Horizon Therapeutics Plc | $52.26 | 2023 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $35.83 | 2024 | Xdemvy |
| Topcon Healthcare, INC. | $16.82 | 2024 | |
| Astellas Pharma US INC | $16.07 | 2023 | |
| Coherus Oncology, INC. | $13.68 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $13.53 | 2023 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.